Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) ยท filed Aug 8, 2023
- Accession no.
- 0001209191-23-044893
- Filed
- Aug 8, 2023, 7:07 AM ET
- Trade date
- Aug 7, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 15 non-derivative transactions. Open-market purchases total $1.19M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +100 | $1.82 | +$181.5 | 200,031,794 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +43,885 | $1.82 | +$79,870.7 | 200,075,679 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +3,400 | $1.82 | +$6,196.5 | 200,079,079 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +54,271 | $1.83 | +$99,044.58 | 200,133,350 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +4,530 | $1.83 | +$8,285.37 | 200,137,880 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +177,580 | $1.83 | +$324,971.4 | 200,315,460 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +500 | $1.83 | +$916.25 | 200,315,960 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +33,564 | $1.84 | +$61,589.94 | 200,349,524 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +70,000 | $1.84 | +$128,800 | 200,419,524 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +100 | $1.84 | +$184.25 | 200,419,624 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +45,527 | $1.85 | +$83,997.32 | 200,465,151 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +9,100 | $1.85 | +$16,825.9 | 200,474,251 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +160,243 | $1.85 | +$296,449.55 | 200,634,494 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +21,432 | $1.86 | +$39,756.36 | 200,655,926 | Indirect | |
| Aug 7, 2023 | Common Stock | PPurchaseAcquired | +25,768 | $1.86 | +$47,928.48 | 200,681,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.